Please use this identifier to cite or link to this item:
https://olympias.lib.uoi.gr/jspui/handle/123456789/23730
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Elisaf, M. S. | en |
dc.contributor.author | Stefanaki-Nikou, S. | en |
dc.contributor.author | Voulgarelis, M. | en |
dc.contributor.author | Masalas, C. | en |
dc.contributor.author | Tsianos, E. V. | en |
dc.date.accessioned | 2015-11-24T19:35:42Z | - |
dc.date.available | 2015-11-24T19:35:42Z | - |
dc.identifier.issn | 0168-8278 | - |
dc.identifier.uri | https://olympias.lib.uoi.gr/jspui/handle/123456789/23730 | - |
dc.rights | Default Licence | - |
dc.subject | Aprindine/*adverse effects/therapeutic use | en |
dc.subject | Arrhythmias, Cardiac/drug therapy | en |
dc.subject | *Drug-Induced Liver Injury | en |
dc.subject | Female | en |
dc.subject | Fibrosis | en |
dc.subject | Granuloma/*chemically induced/pathology/physiopathology | en |
dc.subject | Humans | en |
dc.subject | Inflammation | en |
dc.subject | Liver Diseases/pathology/physiopathology | en |
dc.subject | Liver Function Tests | en |
dc.subject | Male | en |
dc.subject | Middle Aged | en |
dc.subject | Portal System/pathology | en |
dc.title | Aprindine-induced hepatic granulomata | en |
heal.type | journalArticle | - |
heal.type.en | Journal article | en |
heal.type.el | Άρθρο Περιοδικού | el |
heal.identifier.secondary | http://www.ncbi.nlm.nih.gov/pubmed/1500691 | - |
heal.identifier.secondary | http://ac.els-cdn.com/016882789290170T/1-s2.0-016882789290170T-main.pdf?_tid=bf5c999cdcb53a2ee3e37511ab49e1e2&acdnat=1333694951_59436238ef5ffd7fb78db9eac08ac75f | - |
heal.language | en | - |
heal.access | campus | - |
heal.recordProvider | Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής | el |
heal.publicationDate | 1992 | - |
heal.abstract | Aprindine is a very effective antiarrhythmic agent with a narrow therapeutic ratio. We report a patient who suffered from granulomatous hepatitis probably due to the administration of aprindine. Evidence of hepatitis appeared within 6 weeks of initiating aprindine therapy and resolved rapidly when the drug was withdrawn. Six months later, fibrosis but no granulomata were found in the expanded portal tracts. Our observations suggest that granulomatous hepatitis can occur during aprindine therapy. | en |
heal.journalName | J Hepatol | en |
heal.journalType | peer-reviewed | - |
heal.fullTextAvailability | TRUE | - |
Appears in Collections: | Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά) - ΙΑΤ |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
Elisaf-1992-Aprindine-induced he.pdf | 1.31 MB | Adobe PDF | View/Open Request a copy |
This item is licensed under a Creative Commons License